Welcome to our dedicated page for VAS news (Ticker: VAS), a resource for investors and traders seeking the latest updates and insights on VAS stock.
The VAS news page on Stock Titan focuses on information and context related to VIASYS Healthcare, Inc., which is described as a publicly traded medtech firm listed on the New York Stock Exchange. Available information links the VAS ticker to a company with operations in respiratory care, neurology, orthopedics, and surgical products, placing it within the broader healthcare and medical technology space.
Because the provided data set does not include a stream of current company-specific news items, this page primarily serves as a contextual hub for any articles, press releases, or market commentary that reference VIASYS Healthcare, Inc. or the VAS symbol. When news is available, it may touch on topics such as the company’s role in medical technology, references to its historical operations, or mentions in biographical profiles of executives who previously held leadership roles at VIASYS Healthcare.
Users can use this page to review how the VAS ticker and VIASYS Healthcare, Inc. are discussed in publicly available news sources over time. As new coverage appears in the underlying feeds used by Stock Titan, it will be associated with the VAS symbol here, allowing readers to see how the company is referenced in relation to medtech, respiratory care, neurology, orthopedics, and surgical products.
Bookmarking this page can help users quickly return to any aggregated coverage tied to the VAS symbol, while keeping the focus on the documented description of VIASYS Healthcare, Inc. as a publicly traded medtech firm.
Invidia Capital Management has appointed Matt Bennett as Partner, bringing over 30 years of healthcare investment and operational experience to the firm. Bennett previously served as Managing Director and Operating Partner at New Mountain Capital, where he focused on growth transactions. His experience includes CEO roles at CIOX Health and executive positions at Ikaria and VIASYS Healthcare.
Bennett will contribute to Invidia's mission of investing in and scaling innovative healthcare businesses across North America. The appointment strengthens Invidia's healthcare-focused middle-market investment platform under the leadership of Founder and Managing Partner Jo Natauri.